WallStSmart

Hudbay Minerals Inc. (HBM)vsThermo Fisher Scientific Inc (TMO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Thermo Fisher Scientific Inc generates 1915% more annual revenue ($44.56B vs $2.21B). HBM leads profitability with a 25.7% profit margin vs 15.0%. TMO appears more attractively valued with a PEG of 1.76. HBM earns a higher WallStSmart Score of 75/100 (B).

HBM

Strong Buy

75

out of 100

Grade: B

Growth: 7.3Profit: 8.5Value: 10.0Quality: 5.0
Piotroski: 2/9Altman Z: 1.39

TMO

Buy

59

out of 100

Grade: C

Growth: 4.7Profit: 7.0Value: 7.3Quality: 6.3
Piotroski: 3/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HBMUndervalued (+60.8%)

Margin of Safety

+60.8%

Fair Value

$67.39

Current Price

$20.02

$47.37 discount

UndervaluedFair: $67.39Overvalued
TMOSignificantly Overvalued (-27.5%)

Margin of Safety

-27.5%

Fair Value

$384.82

Current Price

$490.77

$105.95 premium

UndervaluedFair: $384.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HBM5 strengths · Avg: 8.2/10
Profit MarginProfitability
25.7%9/10

Keeps 26 of every $100 in revenue as profit

P/E RatioValuation
13.9x8/10

Attractively priced relative to earnings

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Operating MarginProfitability
29.8%8/10

Strong operational efficiency at 29.8%

Revenue GrowthGrowth
25.3%8/10

Revenue surging 25.3% year-over-year

TMO3 strengths · Avg: 8.3/10
Market CapQuality
$182.14B9/10

Large-cap with strong market position

Operating MarginProfitability
21.2%8/10

Strong operational efficiency at 21.2%

Free Cash FlowQuality
$2.99B8/10

Generating 3.0B in free cash flow

Areas to Watch

HBM3 concerns · Avg: 3.0/10
PEG RatioValuation
2.094/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.392/10

Distress zone — elevated risk

TMO3 concerns · Avg: 3.7/10
PEG RatioValuation
1.764/10

Expensive relative to growth rate

P/E RatioValuation
27.6x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : HBM

The strongest argument for HBM centers on Profit Margin, P/E Ratio, Price/Book. Profitability is solid with margins at 25.7% and operating margin at 29.8%. Revenue growth of 25.3% demonstrates continued momentum.

Bull Case : TMO

The strongest argument for TMO centers on Market Cap, Operating Margin, Free Cash Flow.

Bear Case : HBM

The primary concerns for HBM are PEG Ratio, Piotroski F-Score, Altman Z-Score.

Bear Case : TMO

The primary concerns for TMO are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

HBM profiles as a growth stock while TMO is a value play — different risk/reward profiles.

HBM carries more volatility with a beta of 2.03 — expect wider price swings.

HBM is growing revenue faster at 25.3% — sustainability is the question.

TMO generates stronger free cash flow (3.0B), providing more financial flexibility.

Bottom Line

HBM scores higher overall (75/100 vs 59/100), backed by strong 25.7% margins and 25.3% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hudbay Minerals Inc.

BASIC MATERIALS · COPPER · USA

Hudbay Minerals Inc., a diversified mining company, focuses on the discovery, production and marketing of base and precious metals in North and South America. The company is headquartered in Toronto, Canada.

Visit Website →

Thermo Fisher Scientific Inc

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.

Visit Website →

Want to dig deeper into these stocks?